Privi approvals hold back Rs 250-300 crore revenue plan

Privi Fine Sciences said during its earnings call that regulatory approvals expected within the next few months are needed to lift its 6,000-tonne facility toward Rs 250-300 crore of revenue in the next financial year. An analyst cited FY26 turnover of about Rs 68 crore and a Rs 34.28 crore loss at the operation.

What is holding back Privi's plant revenue?

Privi says pending regulatory approvals are preventing production expansion at the facility, although it has five products and already supplies four of them to top multinational customers. Sanjeev Patil said approval delays, rather than product readiness, had stopped the company from expanding capacity, and that the approvals were nearing completion.

The required permissions include approvals from the Pollution Control Board and other authorities, according to Patil. He said the equipment was ready, but Privi could not expand capacity until permissions arrived; management expects this constraint to ease within the next few months and to produce a significant improvement in the next financial year.

This makes regulatory clearance the immediate dependency for the stated revenue plan. Privi did not identify a shortage of installed equipment, customer acceptance, or individual product development as the bottleneck, while it did not disclose the individual approvals, their filing dates, or a fixed date for their receipt.

Why has 85% utilisation not delivered Privi's full revenue potential?

Privi reported capacity utilisation of about 85%, but management said that did not mean the facility's full capacity had been realised. Patil said the portfolio comprises products based on isobutene and that expansion remained impossible until the outstanding permissions were granted.

When asked why the operation had a cited FY26 loss of Rs 34.28 crore despite the 85% utilisation, Patil said full capacity would be realised only after the permissions and that the operation would then break even. The 85% figure therefore refers to the present operating position, not necessarily to the full production and revenue configuration management intends to pursue.

The transcript does not quantify the capacity base used for the 85% utilisation calculation. It does, however, identify 6,000 tonnes of capacity already in place, and Narayan S. Iyer said that capacity could potentially generate Rs 300-350 crore of revenue at prevailing prices once regulatory bottlenecks are removed.

How much revenue does Privi expect approvals to unlock?

Privi expects the facility to generate about Rs 250-300 crore of revenue after approvals allow it to reach the intended 80-85% capacity level. Iyer said the installed 6,000-tonne capacity had potential revenue of about Rs 300-350 crore based on prices then prevailing, making the Rs 250-300 crore range a management expectation rather than reported revenue.

The management range is materially above the roughly Rs 68 crore FY26 turnover cited by analyst Krish Salot. Rs 250 crore is more than three times that FY26 figure, while Rs 300 crore is more than four times it, though the comparison is conditional because the future range depends on approvals and subsequent production ramp-up.

Privi also linked the ramp-up to its planned merger process. Iyer said management expected the merger to be completed before the end of the current financial year, after which Privi would be positioned to pursue manufacturing at the stated 80-85% capacity level.

What shows that Privi's products already have customer acceptance?

Privi says four of the facility's five products are already supplied to top multinational customers, indicating that customer supply has begun before the regulatory expansion is completed. Patil said the business was ready in terms of products, while the unresolved issue was permission to expand production.

Privi did not disclose the names of the five products, customers, contract values, offtake volumes, or revenue contribution by product. It only described the facility portfolio as based on isobutene and other materials, so the call does not establish how the potential Rs 300-350 crore revenue would be distributed across the five products.

The facility issue is separate from Privi's broader Phase 2 programme, which includes maltol, ethyl maltol, furfural and cyclopentanol. Management expects Phase 2 to be completed between June and September of the next year, with revenue contribution beginning from October '27 onwards and potential revenue of close to Rs 1,000 crore at full 12,000-metric-tonne capacity.

When could Privi's financial improvement become visible?

Privi expects the permissions within the next few months and said they were expected “any time now,” but management did not give a firm approval date. Patil said the next financial year should show results closer to the Rs 250-300 crore revenue range, subject to the clearances and expansion of manufacturing.

The merger is a second stated milestone, with Iyer expecting completion before the current financial year ends. Management said the combination of clearance and merger completion would allow Privi to go all out on manufacturing, but it did not provide a monthly production ramp, a break-even date, or a projected profit figure.

Beyond this facility, management said about Rs 1,000 crore remained to be spent across Phases 2 and 3 of a three-phase programme originally outlined at about Rs 1,400 crore. It expects all three phases to support about Rs 1,900 crore of revenue by 2030, including about Rs 450 crore from Phase 1 and about Rs 450-500 crore from Phase 3.

Conclusion

Privi's disclosed constraint is not simply installed capacity: it is the ability to secure regulatory approval to use and expand the existing 6,000-tonne facility as planned. Management's Rs 250-300 crore next-financial-year revenue expectation compares with the Rs 68 crore FY26 turnover cited by an analyst, while the same analyst cited a Rs 34.28 crore loss.

The next items to watch are the approvals management expects within months, merger completion before the current financial year ends, and whether production can move toward the stated 80-85% capacity level. Separately, Privi plans to complete Phase 2 between June and September of the next year, with revenue contribution expected from October '27 onwards.